Stillcanna Founder Relocates to Europe to Concentrate on Bulk CBD Sales
VANCOUVER, July 10, 2019 /CNW/ – StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (FRA: 484) (“STIL” or the “Company”) is pleased to announce its founder Marc Crimeni is relocating to Europe to concentrate on bulk sales of the Company’s CBD products.
“We are a global company operating in multiple time zones,” stated Jason Dussault CEO of Stillcanna. “Marc has spent the majority of his career in global sales and marketing having done business in over 60 countries. His sales and marketing knowledge across a myriad of products over the past 4 decades is instrumental in Stillcanna achieving its corporate milestones, I applaud Marc’s dedication to the task at hand.”
“In the near term the European market for bulk CBD has been forecast to be the largest in the world,” explained Marc Crimeni. “Capitalizing on this opportunity is difficult when faced with an 8 to 10 hour time difference. In founding the Company it was important to me to secure the right team members in management, agriculture, harvesting and extraction so I could concentrate on my core skills in international sales, today we have reached that milestone. I look forward to operating in the same time zone as our facilities and future customers while assisting the Company on achieving its revenue goals moving forward.”
Mr. Crimeni will be relocating to Europe at the end of July 2019.
About Stillcanna Inc.
StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (FRA: 484) www.stillcanna.com is a Canadian early-stage life sciences company focused on large scale CBD extraction in Europe. The company feels its proprietary intellectual property allows it to extract CBD at a lower cost. The company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly BioSciences LLC, a United Kingdom-based supplier of CBD. Upon the completion of its Polish extraction facilities, Stillcanna will be one of the largest processors and providers of market ready CBD in Europe.
On Behalf of the Board
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
Cardinal Health (NYSE:CAH) recently announced steps to position the Company for long-term success, expanding on previously disclosed expansion goals. Elliott Investment Management L.P. (“Elliott”) provided feedback on these efforts. Elliott has also signed a collaboration ... [Read]
The content purge at HBO Max continues with the removal of over 200 older episodes of the iconic children’s program “Sesame Street.” HBO Max’s removal of “Sesame Street” episodes and other current programming appears to ... [Read]
In combination with docetaxel, the U.S. Food and Drug Administration (FDA) has approved Bayer’s Nubeqa for the treatment of hormone-sensitive metastatic prostate cancer (mHSPC).Nubeqa (darolutamide) was previously approved for the treatment of non-metastatic castration-resistant prostate ... [Read]
Canadian car makers breathed a sigh of relief last week when US lawmakers decided to scrap part of a large incentive package for electric vehicles (EVs) that originally excluded EVs assembled in Canada from a ... [Read]
Emergent Health Corp. (“Emergent”) (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc. Biologics, Inc. is a new type of biologics company with a specific mission: to provide the ... [Read]
Alzamend Neuro, Inc. (Nasdaq:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”), and post-traumatic stress disorder (“PTSD”), announced today ... [Read]
Energy business Providence Resources Plc (PVR), based in Ireland, announced that Alan Curran had been named Interim Chief Executive as of July 4. James Menton returns to his position as non-executive Chairman of the Board ... [Read]
Evaxion Biotech A/S (NASDAQ: EVAX) a clinical-stage biotechnology company focused on the creation of AI-driven immunotherapies, announced today that it has chosen EVX-03 as the product candidate within its DNA technology platform to target a ... [Read]
Heritage Cannabis Holdings Corp. has announced that it will debut twenty new products in the Ontario cannabis market, which will be available through the Ontario Cannabis Store (OCS) and other merchants across the province. Loose ... [Read]
Disclosure:
1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.
2) The Article was issued on behalf of a third party, StillCanna Inc. Market Jar Media Inc. has or expects to receive sixty nine thousand canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 15 campaign days (10 business days).
3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.
4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.
Add at end of text:
